Supplementary Figure S10. ULMS genomic risk stratification for disease-specific survival (DSS). A 3-tier genomic risk group is proposed for DSS. DSS for 238 ULMS patients from the MSK cohort in low, intermediate, and high-risk genomic groups is represented by Kaplan-Meier curves (global log-rank P and Benjamin-Hochberg adjusted P-values by pairwise analysis).
No takes yet. Share an insight, caveat, or question.
Dermawan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: